Correlates of Protection Against SIVmac251 Infection in Rhesus Macaques Immunized With Chimpanzee-Derived Adenovirus Vectors
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in EBioMedicine
- Vol. 31, 25-35
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (IPCAVD U19 AI074078)
This publication has 40 references indexed in Scilit:
- DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challengeProceedings of the National Academy of Sciences, 2013
- SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responsesVaccine, 2012
- Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeysNature, 2012
- An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiationInternational Immunology, 2011
- ICOS Receptor Instructs T Follicular Helper Cell versus Effector Cell Differentiation via Induction of the Transcriptional Repressor Bcl6Immunity, 2011
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccineNature, 2011
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in ThailandNew England Journal of Medicine, 2009
- Bcl6 and Blimp-1 Are Reciprocal and Antagonistic Regulators of T Follicular Helper Cell DifferentiationScience, 2009
- Type I interferon (IFN)-dependent activation of Mnk1 and its role in the generation of growth inhibitory responsesProceedings of the National Academy of Sciences, 2009
- Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trialThe Lancet, 2008